Developments and Changes in the Automated Breast Ultrasound System Market

The automated breast ultrasound system is primarily designed to obtain ultrasound images with the help of a broadband transducer which is scanned over the whole breast to capture 3D ultrasound volume data. It provides 3D images and detects cancer in dense breast tissues. The market for automated breast ultrasound system has been segmented by application which includes hospitals and research labs and diagnostic laboratories among others. The automated breast ultrasound system enables quicker scan time, reduces the operator dependence. It also increases the reproducibility, consistency, reliability and sensitivity of each individual full breast ultrasound diagnosis. With the growing prevalence of breast cancer and increasing patient awareness towards the connection of breast density with breast cancer is fueling the demand for automated breast ultrasound system.
Obtain Report Details: http://www.transparencymarketresearch.com/automated-breast-ultrasound-system-market.html
With the growing awareness towards the symptoms of breast cancer along with rising radiology market is some of the major driving factors for the market. Furthermore, growing extensive research and development for upgraded imaging techniques along with increasing government advocation towards the breast cancer awareness is also acting as drivers for the market. Furthermore high maintenance and manufacturing cost of magnetic resonance imaging (MRI), exposure to radiation and lack of expertise in this field is some of the restraining factors which may hinder the growth of this market. However, the benefits obtained from the automated breast ultrasound system such as 3D images and coronal view, less turnaround time along with assurance of improved diagnostic results are stimulating the market at the global level.
With the increasing technological advancement and growing application of automated breast ultrasound system in hospitals and research institutes and diagnostic laboratories are fueling the market globally. North America dominated the market for automated breast ultrasound system followed by Europe in 2014 and is expected to maintain its position over the forecast period 2015 to 2023. U.S. is the major market across North America. Furthermore, increasing awareness towards detecting breast cancer at the primary stage in order to avoid life risks associated with the diseases along with expenditure on research and development activities to upgrade technologies for better accurate results are driving the market across Asia Pacific. Japan, China, India among others contributes in the positive growth of this market across Asia Pacific. Growing number areas of hospitals and imaging diagnostic centers primarily for cancer patients are having a positive impact on the growing market for automated breast ultrasound system in Rest of the World (RoW).
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8449
Some of the major players operating in the automated breast ultrasound system market are Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), General Electric Company (U.S), SonoCine Inc. (U.S.), Hitachi, Ltd.(Japan) among others. Increasing strategic alliances between major companies for better market penetration is one of the major strategies adopted by key players. Furthermore, manufacturers in developing countries are investing in the healthcare and mammography sector in order to provide advance medical instruments which in turn are contributing in the positive growth of automated breast ultrasound system market globally.

2016 Automated Breast Ultrasound System Industry Research Review

The automated breast ultrasound system is primarily designed to obtain ultrasound images with the help of a broadband transducer which is scanned over the whole breast to capture 3D ultrasound volume data. It provides 3D images and detects cancer in dense breast tissues. The market for automated breast ultrasound system has been segmented by application which includes hospitals and research labs and diagnostic laboratories among others. The automated breast ultrasound system enables quicker scan time, reduces the operator dependence. It also increases the reproducibility, consistency, reliability and sensitivity of each individual full breast ultrasound diagnosis. With the growing prevalence of breast cancer and increasing patient awareness towards the connection of breast density with breast cancer is fueling the demand for automated breast ultrasound system.

With the growing awareness towards the symptoms of breast cancer along with rising radiology market is some of the major driving factors for the market. Furthermore, growing extensive research and development for upgraded imaging techniques along with increasing government advocation towards the breast cancer awareness is also acting as drivers for the market. Furthermore high maintenance and manufacturing cost of magnetic resonance imaging (MRI), exposure to radiation and lack of expertise in this field is some of the restraining factors which may hinder the growth of this market. However, the benefits obtained from the automated breast ultrasound system such as 3D images and coronal view, less turnaround time along with assurance of improved diagnostic results are stimulating the market at the global level.

Download Sample PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8449

With the increasing technological advancement and growing application of automated breast ultrasound system in hospitals and research institutes and diagnostic laboratories are fueling the market globally. North America dominated the market for automated breast ultrasound system followed by Europe in 2014 and is expected to maintain its position over the forecast period 2015 to 2023. U.S. is the major market across North America. Furthermore, increasing awareness towards detecting breast cancer at the primary stage in order to avoid life risks associated with the diseases along with expenditure on research and development activities to upgrade technologies for better accurate results are driving the market across Asia Pacific. Japan, China, India among others contributes in the positive growth of this market across Asia Pacific. Growing number areas of hospitals and imaging diagnostic centers primarily for cancer patients are having a positive impact on the growing market for automated breast ultrasound system in Rest of the World (RoW).

Some of the major players operating in the automated breast ultrasound system market are Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), General Electric Company (U.S), SonoCine Inc. (U.S.), Hitachi, Ltd.(Japan) among others. Increasing strategic alliances between major companies for better market penetration is one of the major strategies adopted by key players. Furthermore, manufacturers in developing countries are investing in the healthcare and mammography sector in order to provide advance medical instruments which in turn are contributing in the positive growth of automated breast ultrasound system market globally.

Automated Breast Ultrasound System Market Trends and Forecast 2016 - 2023

Automated breast ultrasound system (ABUS) is designed to acquire ultrasound images of the breast using a broadband transducer when a mammography is unable to detect the breast abnormalities due to the presences of dense tissue. The transducer is scanned over the whole breast, in an automated fashion, to collect three Dimensional (3D) ultrasound volume data without exposing the patients to the radiations and pain. Ultrasound technique provides images in real-time and often with a video of the human anatomy. The Automated breast ultrasound device uses a fully automated process to capture 3D images using a high frequency broadband transducer. The advantage of automated breast ultrasound system over mammography is that automated breast ultrasound system are capable of flowing fluid monitoring as well as identifying abnormal masses in the flowing fluid. Automated breast ultrasound system costs less than most diagnostic imaging techniques. Moreover, ABUS provides safe breast screening without radiation, compression or discomfort to the patient. Growth of the global automated breast ultrasound system is mainly driven by rising prevalence of breast cancer worldwide, growing radiology market and extensive research and development in the imaging techniques. However, factors such as lack of trained personnel with high technical expertise and inadequate insurance coverage coupled with high prices of ABUS devices and high manufacturing and maintenance costs of equipment and accessories are restraining global automated breast ultrasound system market growth.

Browse Full Report: http://www.transparencymarketresearch.com/automated-breast-ultrasound-system-market.html

The global automated breast ultrasound system market has been segmented on the basis of products, end-user and geography. The products segment is categorized depending on the brands such as Invenia (GE Healthcare, SOFIA (Hitachi ltd.), ACUSON S2000 (Siemens AG) and Sonecine (SoneCine, Inc.).  The end-user segment is further sub-segmented into hospitals and diagnostic imaging laboratories. The hospitals segment dominated the global automated breast ultrasound system by end-user in terms of revenue and continue to grow at a steady rate. However, the increasing number of diagnostic imaging laboratories would fuel the growth of the diagnostic imaging laboratories segment. 

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8449

Geographically, North America held the largest share of the global automated breast ultrasound system market, followed by Europe during the forecast period of 2013-2023. The growth of the North American market is likely to be driven due to extensive advancements in the technological front and major market players located in this region. Moreover, rising prevalence of breast cancer in U.S. would drive the demand for automated breast ultrasound system. The American Cancer Society has estimated that 231,840 women are expected to be diagnosed with breast cancer in the U.S. in 2015 while the International Agency for Research on Cancer has stated that there were 458,337 cases of female breast cancer in Europe in 2013.  Europe is the second largest medical device technologies market due to increased geriatric population, rising breast cancer cases and government regulations fueling the market growth. Asia-Pacific is considered as an emerging market owing to the untapped opportunities, advancements in the technology and health care infrastructure and rising awareness about health care advancement. Japan, China and India are the fastest growing economy. Additionally, rising medical tourism in these countries would grow the automated breast ultrasound system in Asia-Pacific. South American countries such as Brazil and Mexico are the regions that have significant potential for growth due to developing medical infrastructure, and high disposable income in these countries. 

Some of the key players operating in this market are General Electronic Co., Hitachi Ltd., Siemens AG, and SonoCine, Inc.